JR Arribas

Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ

Campus Cantoblanco

C/Kelsen, 1

Madrid, Madrid 28049

Spain

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 8,755

SSRN RANKINGS

Top 8,755

in Total Papers Downloads

7,975

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

Number of pages: 38 Posted: 27 May 2021
La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, Instituto de Salud Carlos III- Laboratorio de Serología, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - Laboratorio de Serología, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, University Hospital 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica and Independent
Downloads 7,741 (1,238)
Citation 11

Abstract:

Loading...

2.

Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial

Number of pages: 34 Posted: 03 Aug 2022
University of Oslo - Section for Clinical Immunology and Infectious Diseases, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Sorbonne University, University of Oslo - Institute of Clinical Medicine, University of Lille, affiliation not provided to SSRN, University of Verona, Hospital Universitario Virgen Macarena - Unidad Clínica de Enfermedades Infecciosas, affiliation not provided to SSRN, affiliation not provided to SSRN, Medical University of Innsbruck, Universidade do Porto, affiliation not provided to SSRN, affiliation not provided to SSRN, Oslo University Hospital, Oslo University Hospital, Oslo University Hospital, Sorbonne University, University of Oslo - Division of Emergencies and Critical Care, University of Claude Bernard Lyon 1, affiliation not provided to SSRN, University of Pécs, National and Kapodistrian University of Athens, University Hospital Brno, University of Basel - University Hospital Basel, Hacettepe University, Technical University of Munich, Hospices Civils de Lyon - Département des Maladies Infectieuses et Tropicales, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Oslo University Hospital, Sorbonne University, Oslo University Hospital, affiliation not provided to SSRN, Vestre Viken Hospital Trust, affiliation not provided to SSRN, University of Oslo - Institute of Clinical Medicine, Stavanger University Hospital, La Paz University Hospital, Vestre Viken Hospital Trust, University Hospital North Norway, Hospices Civils de Lyon, University of Oslo - Institute of Clinical Medicine, Norwegian Institute of Public Health, Sorbonne University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Oslo - Department of Immunology and Transfusion Medicine, Hospices Civils de Lyon - Laboratoire de Virologie, affiliation not provided to SSRN, Oslo University Hospital, Norwegian Institute of Public Health, University of Verona - Infectious Diseases Unit, affiliation not provided to SSRN, University of Oslo - Department of Research Support for Clinical Trials and Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP
Downloads 167 (259,512)

Abstract:

Loading...

COVID-19, immunomodulator, safety, baricitinib, JAK inhibitor

Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

Number of pages: 39 Posted: 21 Mar 2022
Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), affiliation not provided to SSRN, affiliation not provided to SSRN, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, affiliation not provided to SSRN, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Instituto de Salud Carlos III- Laboratorio de Serología, Carlos III Institute of Health - AIDS Immunopathogenesis Unit and Independent
Downloads 38 (628,405)

Abstract:

Loading...

SARS-CoV-2, heterologous vaccination, Neutralisation, Variants, antibodies

4.

Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS Study

Number of pages: 27 Posted: 01 Mar 2022
Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz, Hospital Universitario La Paz - Department of Laboratory Medicine, Hospital Universitario La Paz, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, Hospital Universitario La Paz, Hospital Universitario La Paz, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, La Paz University Hospital - Servicio de Farmacología Clínica, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ and Hospital Universitario La Paz
Downloads 29 (670,648)

Abstract:

Loading...

COVID-1, heterologous vaccination, haemostasis